Secondary Faculty Appointments
Christie Ballantyne, M.D.
Clinical and translational research in patients with lipid disorders for the prevention and treatment of cardiovascular disease.
Alison A. Bertuch, M.D., Ph.D.
Basic mechanisms of telomere maintenance, structure, and function and DNA repair in the yeast model organism and human cells; the role of telomere biology in tumorigenesis and bone marrow failure.
Malcolm K. Brenner, M.D., Ph.D.
Use of gene therapy to improve responses to cancer.
Lawrence Chan, M.B., B.S., D.Sc.
Molecular pathogenesis and gene and cell therapy of diabetes; the role of bone marrow cells in diabetic complications.
Edward C. Cooper, M.D., Ph.D.
Voltage-gated sodium and potassium channel diseases of the axon: evolution, mechanisms, animal models, and therapeutics.
Margaret A. Goodell, Ph.D.
Murine and human hematopoietic stem cells; genetic and epigenetic regulation and development.
Yongtao Guan, Ph.D.
Statistical genetics/genomics, Statistical and computational methods for next-gen sequencing, Bayesian statistics, and Markov chain Monte Carlo.
Kendal D. Hirschi, Ph.D.
Analysis of nutrient and metal transporters in Arabidopsis and agriculturally important crops.
Adam Kuspa, Ph.D.
Studies of cell signaling in bacterial recognition and development in the social amoeba Dictyostelium.
Richard A. Lewis, M.D., M.S.
Studies of recessive and X-linked hereditary eye disorders, especially those afflicting infants and children, and constitutional disorders with major ocular involvement.
Martin M. Matzuk, M.D., Ph.D.
Mammalian reproduction, TGF-beta signaling pathways, and ovarian cancer.
David D. Moore, Ph.D.
Functions of members of the nuclear hormone receptor superfamily.
Paolo M. Moretti, M.D.
Genetic and molecular studies of disease pathogenesis in Parkinson’s diseases and traumatic brain injury.
Jeffrey L. Neul, M.D., Ph.D.
Determination of neuroanatomical, cellular, and molecular pathogenic mechanisms of clinical abnormalities in Rett syndrome
Jeffrey L. Noebels, M.D., Ph.D.
Gene control of neuronal excitability within the developing mammalian CNS.
Paul A. Overbeek, Ph.D.
Gene regulation in transgenic mice; ocular development; growth factors; insertional mutagenesis.
Donald W. (Will) Parsons, M.D., Ph.D.
Genomic analysis of pediatric cancers for identification of biologically and clinically-relevant molecular targets.
Sharon E. Plon, M.D., Ph.D.
Cancer predisposition syndromes, mechanisms of genomic instabiity and use of genome sequencing in clinical medicine.
Ignatia B. Van den Veyver, M.D.
Genetics of X-linked disorders (Aicardi, Goltz and MLS syndrome); Epigenetics; DNA methylation in development; Imprinting in hydatidiform moles.
James Versalovic, M.D., Ph.D.
Genomics of Gut Microbes, Intestinal Microbiome, Mucosal Immunity, Gut Inflammation, and Colorectal Cancer.
Robert A. Waterland, Ph.D.
Environmental influences on mammalian developmental epigenetics.
John H. Wilson, Ph.D.
Instability of disease-causing trinucleotide repeats in human cells, and targeted gene therapy of retinitis pigmentosa in mouse models.